Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness v. Acon

This article was originally published in The Gray Sheet

Executive Summary

Boston federal court grants preliminary sales injunction against Acon Laboratories' "sandwich-type immunoassay tests," including strep, pregnancy and ovulation tests, Inverness reports July 19. Inverness anticipates a sales increase as the firm obtains accounts with former Acon customers, but also expects to fall short of Q2 guidance due to higher legal expenses and "shifts in revenue mix." The suit related to Inverness' '982 patent, which the court found to be infringed. A trial slated for early November will assess Acon's patent validity challenge...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020620

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel